Nexturastat A
CAS No. 1403783-31-2
Nexturastat A( Nexturastat A )
Catalog No. M11689 CAS No. 1403783-31-2
A potent and selective HDAC6 inhibitor with IC50 of 5 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 81 | In Stock |
|
10MG | 105 | In Stock |
|
25MG | 177 | In Stock |
|
50MG | 286 | In Stock |
|
100MG | 426 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNexturastat A
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective HDAC6 inhibitor with IC50 of 5 nM.
-
DescriptionA potent and selective HDAC6 inhibitor with IC50 of 5 nM; displays >100-fold selectivity over other HDAC isozymes (600-fold relative to the inhibition of HDAC1).
-
In VitroWestern Blot Analysis Cell Line:B16 murine melanoma cells Concentration:0-10 μM Incubation Time:24 h Result:Increased the level of acetyl α-tubulin levels in a dose-dependent.Cell Viability Assay Cell Line:RPMI-8226 and U266 cells Concentration:0-40 μM Incubation Time:48 h Result:Impaired multiple myeloma (MM) cells viability in a dose- and time-dependent manner.Apoptosis Analysis Cell Line:RPMI-8226 and U266 cells Concentration:0, 30, 40 μM Incubation Time:48 h Result:Induced cell apoptosis in human MM cells.RT-PCRCell Line:RPMI-8226 and U266 cells Concentration:30 μM Incubation Time:48 h Result:Increased the levels of p21 mRNA in RPMI-8226 and U266 cells.
-
In Vivo——
-
SynonymsNexturastat A
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC6
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1403783-31-2
-
Formula Weight341.4042
-
Molecular FormulaC19H23N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 56 mg/mL
-
SMILESO=C(NO)C1=CC=C(CN(CCCC)C(NC2=CC=CC=C2)=O)C=C1
-
Chemical NameBenzamide, 4-[[butyl[(phenylamino)carbonyl]amino]methyl]-N-hydroxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bergman JA, et al. J Med Chem. 2012 Nov 26;55(22):9891-9.
2. Miyake Y, et al. Nat Chem Biol. 2016 Sep;12(9):748-54.
molnova catalog
related products
-
SBHA
SBHA (suberohydroxamic acid) is a Histone deacetylase (HDAC) inhibitor. HDAC is required for transcriptional modulation, cell cycle regulation and development.
-
Remodelin
A potent inhibitor of the acetyl-transferase protein NAT10 that acetylates both histones and microtubules.
-
AES-350
AES-350 is a potent and orally active HDAC6 inhibitor(IC50 and a Ki of 0.0244 μM and 0.035 μM, respectively).